Weill Cornell researchers develop novel antibody vaccine that blocks addictive nicotine chemicals from reaching the brain. Researchers at Weill Cornell...
Weill Neurohub announces a long-term research partnership with Genentech and Roche Holding AG to advance the development of new therapeutics for debilitating brain and central nervous system diseases.
New research reveals the key chemical process that corrects for potential visual errors in low-light conditions. Understanding this fundamental step could lead to new treatments for visual deficits, or might one day boost normal night vision to new levels.
The experimental treatment method allows small therapeutic agents to safely cross the blood-brain barrier in laboratory rats by turning off P-glycoprotein, one of the main gatekeepers preventing medicinal drugs from reaching their intended targets in the brain.
Neuroscientists have believed that three brain regions are critical for self-awareness: the insular cortex, the anterior cingulate cortex, and the medial prefrontal cortex. Patient R is helping a research team show that self-awareness is more a product of a diffuse patchwork of pathways in the brain—including other regions—rather than confined to specific areas.
New research would help emergency care workers and battlefield medics stabilize blood flow in the brains of traumatic injury victims. Researchers developed a nanoparticle-based antioxidant that quickly quenches free radicals that interfere with regulation of the brain’s vascular system.
Working with mice, Johns Hopkins researchers say they have figured out how stem cells found in a part of the brain responsible for learning, memory and mood regulation decide to remain dormant or create new brain cells. Apparently, the stem cells “listen in” on the chemical communication among nearby neurons to get an idea about what is stressing the system and when they need to act.
Analysis of recent H1N1 vaccination data indicated a small but significant risk of Guillain-Barre Syndrome following influenza A(H1N1) vaccinations.
A new survey of stroke survivors has shown that those with post-traumatic stress disorder (PTSD) are less likely to adhere to treatment regimens that reduce the risk of an additional stroke.